RankAlpha logo
Back to Rankings

KPTI

Karyopharm TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
The constructive read is that KPTI still has two meaningful 2026 shots on goal: more detailed SENTRY data at ASCO on June 2, 2026 and the mid-2026 XPORT-EC-042 readout, while the March financing bought enough time to reach those milestones [#PR-2026-04-21] [#8-K-2026-03-27].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +12.2.
What can break
Liquidity guidance still points only into late Q3 2026 even after the March financing, keeping dilution, debt amendment, partnering or other capital actions in play [#8-K-2026-03-27].
Momentum
85
Value
41
Sentiment
39
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.50 · Bull $14.50 · Bear $4.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-03 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $15.33
Why
Momentum85 · Δ7d +12.2
Value41 · Δ7d +0.1
Sentiment39 · Δ7d -14.9
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
85
34% active weight
Current posture
7d trendImproving
Δ7d
+12.2
Δ21d
-5.1
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
39
33% active weight
Current posture
7d trendSoftening
Δ7d
-14.9
Δ21d
-2.7
Why this grade

Composite grade B. Momentum 85.3 / Value 41.1 / Sentiment 39.1

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$222.55M
Beta
0.21
Shares Out
17.05M
P/E (TTM) · Derived
-0.7
P/S (TTM)
0.89
P/FCF (TTM) · Derived
-1.25
Rev YoY
+13.6%
EPS YoY
+0.7%
Gross Margin
+95.9%
Op Margin
-73.1%
Net Debt
$152.16M
Current Ratio
1.03
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology